Captor Therapeutics Spolka Akcyjna (CTX.WA)

PLN 32.2

(1.58%)

Total Assets Summary of Captor Therapeutics Spolka Akcyjna

  • Captor Therapeutics Spolka Akcyjna's latest annual total assets in 2023 was 97.29 Million PLN , down -13.9% from previous year.
  • Captor Therapeutics Spolka Akcyjna's latest quarterly total assets in 2024 Q2 was 77.65 Million PLN , down -6.97% from previous quarter.
  • Captor Therapeutics Spolka Akcyjna reported annual total assets of 113 Million PLN in 2022, down -21.28% from previous year.
  • Captor Therapeutics Spolka Akcyjna reported annual total assets of 143.54 Million PLN in 2021, up 456.81% from previous year.
  • Captor Therapeutics Spolka Akcyjna reported quarterly total assets of 83.46 Million PLN for 2024 Q1, down -14.21% from previous quarter.
  • Captor Therapeutics Spolka Akcyjna reported quarterly total assets of 72.54 Million PLN for 2023 Q3, down -7.32% from previous quarter.

Annual Total Assets Chart of Captor Therapeutics Spolka Akcyjna (2023 - 2017)

Historical Annual Total Assets of Captor Therapeutics Spolka Akcyjna (2023 - 2017)

Year Total Assets Total Assets Growth
2023 97.29 Million PLN -13.9%
2022 113 Million PLN -21.28%
2021 143.54 Million PLN 456.81%
2020 25.77 Million PLN 1.9%
2019 25.29 Million PLN 40.07%
2018 18.06 Million PLN 252.48%
2017 5.12 Million PLN 0.0%

Peer Total Assets Comparison of Captor Therapeutics Spolka Akcyjna

Name Total Assets Total Assets Difference
Bioceltix S.A. 12.73 Million PLN -663.971%
BIOTON S.A. 822.22 Million PLN 88.167%
Mabion S.A. 208.25 Million PLN 53.281%
Molecure S.A. 168.57 Million PLN 42.285%
NanoGroup S.A. 8.63 Million PLN -1027.186%
Pharmena S.A. 24.13 Million PLN -303.174%
Poltreg S.A. 127.09 Million PLN 23.45%
Pure Biologics Spólka Akcyjna 22.73 Million PLN -327.892%
Ryvu Therapeutics S.A. 403.2 Million PLN 75.87%
Synthaverse S.A. 265.9 Million PLN 63.41%
Urteste S.A. 29.59 Million PLN -228.718%